Optimal hemoglobin A1C Cutoff Value for Diagnosing type 2 diabetes mellitus in Korean adults

Diabetes Research and Clinical Practice

Volumn 99, Issue 2, 2013, Pages 231-236

  Lee, Hyejin ^a   Oh, Jee Young ^a   Sung, Yeon Ah ^a   Kim, Dong Jun ^b   Kim, Sung Hoon ^c   Kim, Sin Gon ^d   Moon, Sungdae ^e   Park, Ie Byung ^f   Rhee, Eun Jung ^g   Chung, Choon Hee ^h   Kim, Byung Joon ⁱ   Ku, Bon Jeong ^j  

^a Ewha Womans University School of Medicine   (South Korea)

^b Inje University   (South Korea)

^c Catholic Kwandong University   (South Korea)

^d Korea University   (South Korea)

^e The Catholic University of Korea   (South Korea)

^f Gachon University   (South Korea)

^g Sungkyunkwan University   (South Korea)

^h Yonsei University   (South Korea)

ⁱ Konyang University   (South Korea)

^j Chungnam National University   (South Korea)

more..

Author keywords

Diabetes; Diagnosis; HbA1C

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; DIAGNOSTIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; AGED; AREA UNDER THE CURVE; ARTICLE; ASIAN; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; KOREAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; ADOLESCENT; GLUCOSE TOLERANCE TEST;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; YOUNG ADULT;

EID: 84876700465     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.09.030     Document Type: Article

References (38)

1. Harris M.I. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993, 16:642-652.
2. Thompson T.J., Engelgau M.M., Hegazy M., Ali M.A., Sous E.S., Badran A., et al. The onset of NIDDM and its relationship to clinical diagnosis in Egyptian adults. Diabet Med 1996, 13:337-340.
3. Wang F.H., Liang Y.B., Zhang F., Wang J.J., Wei W.B., Tao Q.S., et al. Prevalence of diabetic retinopathy in rural China: The Handan Eye Study. Ophthalmology 2009, 116:461-467.
4. Qin X., Li J., Zhang Y., Ma W., Fan F., Wang B., et al. Prevalence and associated factors of diabetes and impaired fasting glucose in Chinese hypertensive adults aged 45-75 years. PLoS ONE 2012, 7:e42538. [Epub 2012 August 3].
5. Nguyen T.T., Wang J.J., Wong T.Y. Retinal vascular changes in pre-diabetes and prehypertension: new findings and their research and clinical implications. Diabetes Care 2007, 30:2708-2715.
6. Report of a WHO/IDF consultation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia; 2006.
7. Barrett-Connor E., Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study. Diabetes Care 1998, 21:1236-1239.
8. Must A., Spadano J., Coakley E.H., Field A.E., Colditz G., Dietz W.H. The disease burden associated with overweight and obesity. JAMA 1999, 282:1523-1529.
9. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-34.
10. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl. 1):S62-69.
11. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27(Suppl. 1):S5-10.
12. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
13. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007;30:2399-400.
14. Sacks D.B., Bruns D.E., Goldstein D.E., Maclaren N.K., McDonald J.M., Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002, 48:436-472.
15. Ollerton R.L., Playle R., Ahmed K., Dunstan F.D., Luzio S.D., Owens D.R. Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects. Diabetes Care 1999, 22:394-398.
16. Selvin E., Crainiceanu C.M., Brancati F.L., Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007, 167:1545-1551.
17. Tapp R.J., Tikellis G., Wong T.Y., Harper C.A., Zimmet P.Z., Shaw J.E. Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care 2008, 31:1349-1354.
18. Bennett C.M., Guo M., Dharmage S.C. HbA(1c) as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med 2007, 24:333-343.
19. Kramer C.K., Araneta M.R., Barrett-Connor E. A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care 2010, 33:101-103.
20. Lu Z.X., Walker K.Z., O'Dea K., Sikaris K.A., Shaw J.E. A1C for screening and diagnosis of type 2 diabetes in routine clinical practice. Diabetes Care 2010, 33:817-819.
21. Hu Y., Liu W., Chen Y., Zhang M., Wang L., Zhou H., et al. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 2010, 47:231-236.
22. Kumar P.R., Bhansali A., Ravikiran M., Bhansali S., Dutta P., Thakur J.S., et al. Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study. J Clin Endocrinol Metab 2010, 95:2832-2835.
23. Buell C., Kermah D., Davidson M.B. Utility of A1C for diabetes screening in the 1999-2004 NHANES population. Diabetes Care 2007, 30:2233-2235.
24. Inoue K., Matsumoto M., Kobayashi Y. The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers. Diabetes Res Clin Pract 2007, 77:451-458.
25. Bae J.C., Rhee E.J., Lee W.Y., Park S.E., Park C.Y., Oh K.W., et al. Optimal range of HbA1c for the prediction of future diabetes: a 4-year longitudinal study. Diabetes Res Clin Pract 2011, 93:255-259.
26. Choi S.H., Kim T.H., Lim S., Park K.S., Jang H.C., Hemoglobin Cho N.H. A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year community-based prospective study. Diabetes Care 2011, 34:944-949.
27. Davidson M.B., Schriger D.L. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract 2010, 87:415-421.
28. Pani L.N., Korenda L., Meigs J.B., Driver C., Chamany S., Fox C.S., et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008, 31:1991-1996.
29. Wiener K., Roberts N.B. Age does not influence levels of HbA1c in normal subject. QJM 1999, 92:169-173.
30. Vallee Polneau S., Lasserre V., Fonfrede M., Delattre J., Benazeth S. A different approach to analyzing age-related HbA1c values in non-diabetic subjects. Clin Chem Lab Med 2004, 42:423-428.
31. Nakashima K., Nishizaki O., Andoh Y. Acceleration of hemoglobin glycation with aging. Clin Chim Acta 1993, 215:111-118.
32. Kilpatrick E.S., Dominiczak M.H., Small M. The effects of ageing on glycation and the interpretation of glycaemic control in type 2 diabetes. QJM 1996, 89:307-312.
33. Rohlfing C.L., Little R.R., Wiedmeyer H.M., England J.D., Madsen R., Harris M.I., et al. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 2000, 23:187-191.
34. Nakagami T., Tominaga M., Nishimura R., Yoshiike N., Daimon M., Oizumi T., et al. Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes? Japan National Diabetes Survey. Diabetes Res Clin Pract 2007, 76:251-256.
35. Wiener K., Roberts N.B. The relative merits of haemoglobin A1c and fasting plasma glucose as first-line diagnostic tests for diabetes mellitus in non-pregnant subjects. Diabet Med 1998, 15:558-563.
36. van't Riet E., Alssema M., Rijkelijkhuizen J.M., Kostense P.J., Nijpels G., Dekker J.M. Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study. Diabetes Care 2010, 33:61-66.
37. Cohen R.M., Smith E.P. Frequency of HbA1c discordance in estimating blood glucose control. Curr Opin Clin Nutr Metab Care 2008, 11:512-517.
38. Herman W.H., Ma Y., Uwaifo G., Haffner S., Kahn S.E., Horton E.S., et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007, 30:2453-2457.